Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,553 Reduced 12.41% |
$261,820
$73.69 p/Share
|
Jan 08
2025 |
|
ACLX
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct | 13,837 Reduced 10.55% |
$1,019,648
$73.69 p/Share
|
Jan 08
2025 |
|
MGTX
|
Alexandria Forbes
PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 11,661 Reduced 0.84% |
$73,464
$6.3 p/Share
|
Jan 08
2025 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 33,751 Reduced 0.0% |
$2,655,866
$78.69 p/Share
|
Jan 08
2025 |
|
APGE
|
Michael Thomas Henderson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.13% |
$735,750
$49.05 p/Share
|
Jan 08
2025 |
|
ENCP
|
Sukses Engineering Sdn Bhd Suria
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,645,916 Reduced 19.06% |
$773,580
$0.47 p/Share
|
Jan 08
2025 |
|
BUKS
|
Joseph Patrick Daly
Director |
BUY
Open market or private purchase
|
Direct | 6,500 Added 0.16% |
$11,180
$1.72 p/Share
|
Jan 08
2025 |
|
RVLV
|
Mmmk Development, Inc. |
SELL
Open market or private sale
|
Direct | 45,987 Reduced 100.0% |
$1,409,961
$30.66 p/Share
|
Jan 08
2025 |
|
RVLV
|
Michael Karanikolas
CO-CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 45,987 Reduced 0.0% |
$1,409,961
$30.66 p/Share
|
Jan 08
2025 |
|
RVLV
|
Michael Mente
CO-CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 45,987 Reduced 0.0% |
$1,409,961
$30.66 p/Share
|
Jan 08
2025 |
|
INSM
|
Roger Adsett
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,882 Reduced 1.27% |
$124,400
$66.1 p/Share
|
Jan 08
2025 |
|
INSM
|
William Lewis
Chair and CEO |
SELL
Open market or private sale
|
Direct | 3,999 Reduced 1.06% |
$263,774
$65.96 p/Share
|
Jan 08
2025 |
|
INSM
|
John Drayton Wise
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 392 Reduced 0.33% |
$25,954
$66.21 p/Share
|
Jan 08
2025 |
|
INSM
|
Orlov S Nicole Schaeffer
Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct | 1,209 Reduced 1.24% |
$79,600
$65.84 p/Share
|
Jan 08
2025 |
|
INSM
|
Sara Bonstein
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,464 Reduced 1.28% |
$96,697
$66.05 p/Share
|
Jan 08
2025 |
|
FUBO
|
Alberto Horihuela
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 29,358 Reduced 1.99% |
$176,148
$6.0 p/Share
|
Jan 08
2025 |
|
INSM
|
Martina M.D. Flammer
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,702 Reduced 1.66% |
$112,604
$66.16 p/Share
|
Jan 08
2025 |
|
INSM
|
Michael Alexander Smith
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,064 Reduced 1.62% |
$70,447
$66.21 p/Share
|
Jan 08
2025 |
|
UNOV
|
Jeff P. H. Cazeau |
BUY
Open market or private purchase
|
Direct | 72,555 Added 18.54% |
$10,157
$0.14 p/Share
|
Jan 08
2025 |
|
JELD
|
Turtle Creek Asset Management Inc. |
BUY
Open market or private purchase
|
Indirect | 160,000 Added 0.0% |
$1,233,600
$7.71 p/Share
|
Jan 08
2025 |
|
ZYME
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 21,021 Added 0.0% |
$295,765
$14.07 p/Share
|
Jan 08
2025 |
|
RSI
|
Richard Todd Schwartz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 149,605 Reduced 6.5% |
$2,185,729
$14.61 p/Share
|
Jan 08
2025 |
|
PFSI
|
David Spector
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$497,950
$99.59 p/Share
|
Jan 08
2025 |
|
FBK
|
James W. Ayers
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.02% |
$100,520
$50.26 p/Share
|
Jan 08
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 21,500 Added 0.0% |
$145,770
$6.78 p/Share
|
Jan 08
2025 |
|
AVGO
|
Eddy W Hartenstein
Director |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.0% |
$918,560
$229.64 p/Share
|
Jan 08
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.43% |
$990,299
$132.04 p/Share
|
Jan 08
2025 |
|
HNRA
|
Pogo Royalty, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 429,125 Reduced 21.45% |
$652,270
$1.52 p/Share
|
Jan 08
2025 |
|
WYTC
|
William Henry Gray
CEO |
BUY
Open market or private purchase
|
Direct | 100 Added 0.0% |
$100
$1.0 p/Share
|
Jan 08
2025 |
|
CVI
|
Icahn Carl C
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 878,212 Added 0.0% |
$16,027,369
$18.25 p/Share
|
Jan 08
2025 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect | 107 Reduced 0.0% |
$4,761
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct | 1,552 Reduced 1.48% |
$69,064
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Mark Elliott Boulding
EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct | 1,998 Reduced 1.84% |
$88,911
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Lee Scott Golden
EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,198 Reduced 1.5% |
$53,311
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Matthew B. Klein
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,402 Reduced 0.84% |
$106,889
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Eric Pauwels
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,136 Reduced 2.4% |
$95,052
$44.5 p/Share
|
Jan 08
2025 |
|
PTCT
|
Christine Marie Utter
SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 1,662 Reduced 2.52% |
$73,959
$44.5 p/Share
|
Jan 08
2025 |
|
RM
|
Forager Fund, L.P. |
SELL
Open market or private sale
|
Direct | 7,555 Reduced 0.72% |
$247,803
$32.8 p/Share
|
Jan 08
2025 |
|
PCF
|
Moritz A Sell
Director |
BUY
Open market or private purchase
|
Direct | 1,624 Added 22.97% |
$10,556
$6.5 p/Share
|
Jan 08
2025 |
|
RSMDF
|
Brett Sandercock
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.07% |
$234,040
$234.04 p/Share
|
Jan 08
2025 |
|
MDT
|
Brett A. Wall
EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct | 9,850 Reduced 19.48% |
$792,038
$80.41 p/Share
|
Jan 08
2025 |
|
ENCP
|
Swee Guan Hoo
Director |
SELL
Open market or private sale
|
Direct | 521,788 Reduced 100.0% |
$240,022
$0.46 p/Share
|
Jan 08
2025 |
|
KMX
|
Mohammad Shamim
EVP and CITO |
SELL
Open market or private sale
|
Direct | 12,845 Reduced 52.25% |
$1,052,519
$81.94 p/Share
|
Jan 08
2025 |
|
ASA
|
Alexander Merk
COO |
BUY
Open market or private purchase
|
Direct | 700 Added 0.32% |
$15,169
$21.67 p/Share
|
Jan 08
2025 |
|
CADL
|
William Garrett Nichols
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 10,799 Reduced 10.74% |
$88,767
$8.22 p/Share
|
Jan 08
2025 |
|
NTAP
|
Michael J Berry
EVP, CFO |
SELL
Open market or private sale
|
Indirect | 12,500 Reduced 0.0% |
$1,459,250
$116.74 p/Share
|
Jan 08
2025 |
|
CADL
|
Seshu Tyagarajan
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 14,545 Reduced 11.58% |
$119,559
$8.22 p/Share
|
Jan 08
2025 |
|
CADL
|
Paul Peter Tak
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,172 Reduced 7.18% |
$174,033
$8.22 p/Share
|
Jan 08
2025 |
|
CADL
|
Charles Schoch |
SELL
Open market or private sale
|
Direct | 9,971 Reduced 15.95% |
$81,961
$8.22 p/Share
|
Jan 08
2025 |
|
CADL
|
Francesca Barone
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 13,673 Reduced 9.92% |
$112,392
$8.22 p/Share
|
Jan 08
2025 |